UNCY
NASDAQ · Biotechnology
Unicycive Therapeutics Inc
$4.64
-0.06 (-1.17%)
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Price Target
Analyst Price Target
+35.1% upside
Low Target
$3.63
Average Target
$6.27
High Target
$7.20
Current Price
$4.64
Current
$4.64
$4.64
Target
$6.27
$6.27
$3.63
$6.27 avg
$7.20
Scenario Analysis
Bear Case
$3.63
-21.8%
Low target
Base Case
$6.27
+35.1%
Avg target
Bull Case
$7.20
+55.2%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$8.74
-46.9% from high
52-Week Low
$3.71
+25.1% from low
Target vs 52W High
$6.27
-28.3% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -2.2% |
| AMGN | Hold | 43 | 47% | $190.87 | -54.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +140.7% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -16.6% |
| REGN | Buy | 38 | 68% | $76.80 | -89.8% |
| MRNA | Hold | 30 | 37% | $149.45 | -24.8% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -65.2% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -43.5% |